Assessment of Bone Marrow Involvement in Extranodal NK/T-Cell Lymphoma: Positron Emission Tomography versus Bone Marrow Biopsy, and the Significance of Minimal Involvement by EBV+ Cells (KROG 18-09)

키워드

참고문헌 (23)

1. Alaggio R, "The 5th edition of the World Health Organization classification of haematolymphoid tumours : lymphoid neoplasms", Leukemia, 36, pp.1720~1748 (2022)
2. Tse E, "The diagnosis and management of NK", Tcell lymphomas, 2017, pp.10, 85~
3. Perry AM, "Non-Hodgkin lymphoma in the developing world : review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project", Haematologica, 101, pp.1244~1250 (2016)
4. Tse E, "How we treat NK", T-cell lymphomas, 2022, pp.15, 74~
5. Yang Y, "Association of improved locoregional control with prolonged survival in early-stage extranodal nasal-type natural killer", T-cell lymphoma, 2017, pp.3, 83~91
6. Deng XW, "Radiotherapy is essential after complete response to asparaginase-containing chemotherapy in early-stage extranodal nasal-type NK", T-cell lymphoma : a multicenter study from the China Lymphoma Collaborative Group(CLCG), 2018, pp.129, 3~9
7. Fujiwara H, "The utility of positron emission tomography", computed tomography in the staging of extranodal natural killer, Eur J Haematol, pp.2011, 87[DOI]
8. Moon SH, "The role of 18F-FDG PET", CT for initial staging of nasal type natural killer, J Nucl Med, pp.2013, 54[DOI]
9. Qi SN, "Modern radiation therapy for extranodal nasal-type NK", T-cell lymphoma : risk-adapted therapy, target volume, and dose guidelines from the International Lymphoma Radiation Oncology Group, 2021, pp.110, 1064~1081
10. "NCCN Clinical Practice Guidelines in Oncology: T-cell lymphomas, version 1.2023" (2023)[URL]
11. Tilly H, "Diffuse large B-cell lymphoma(DLBCL) : ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up", Ann Oncol, 26(Suppl 5), pp.v116~v125 (2015)
12. Eichenauer DA, "Hodgkin lymphoma : ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up", Ann Oncol, 29, pp.iv19~iv29 (2018)
13. Zhou Z, "Evaluation of bone marrow involvement in extranodal NK", T cell lymphoma by FDG-PET, Ann Hematol, pp.2015, 94[DOI]
14. Wang Y, "PET", CTbased bone-marrow assessment shows potential in replacing routine bone-marrow biopsy in part of patients newly diagnosed with extranodal natural killer, J Cancer Res Clin Oncol, pp.2019, 145[DOI]
15. Koh Y, "FDG PET for evaluation of bone marrow status in T-cell lymphoma", Clin Nucl Med, 44, pp.4~10 (2019)
16. Yang C, "(18)F-FDG PET", CT plays a limited role in replacing bone marrow biopsy for newly diagnosed advanced-stage patients with extranodal natural killer, Front Oncol, pp.2022, 12[DOI]
17. Yang Y, "The value of routine bone marrow examination in patients with extranodal NK", T-cell lymphoma staged with PET, Cancer, pp.2022, 128[DOI]
18. Cheson BD, "Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma : the Lugano classification", J Clin Oncol, 32, pp.3059~3068 (2014)
19. Benjamini Y, "Controlling the false discovery rate : a practical and powerful approach to multiple testing", J R Stat Soc Series B Methodol, 57, pp.289~300 (1995)
20. Lee J, "Effect of positive bone marrow EBV in situ hybridization in staging and survival of localized extranodal natural killer", T-cell lymphoma, nasal-type, 2007, pp.13, 3250~3254
21. Huang WT, "Bone marrow that is positive for Epstein-Barr virus encoded RNA-1 by in situ hybridization is related with a poor prognosis in patients with extranodal natural killer", Tcell lymphoma, nasal type, 2005, pp.90, 1063~1069
22. Ito Y, "EBV-encoded RNA1-positive cells in the bone marrow specimens of patients with EBV-negative lymphomas and sarcomas", Pathol Int, 69, pp.392~397 (2019)
23. Farrell D, "Epstein-Barr virus incidental expression in bone marrow cells : a study of 230 consecutive bone marrow biopsy samples", Hum Pathol, 88, pp.60~65 (2019)

관련 논문AI추천